Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




Mitoses Counted with Digital Pathology in Breast Phyllodes Tumors

By LabMedica International staff writers
Posted on 26 Nov 2020
Phyllodes tumors (PTs) are a fibroepithelial tumor composed of an epithelial and a cellular stromal component. They may be considered benign, borderline, or malignant depending on histologic features including stromal cellularity, infiltration at the tumor's edge, and mitotic activity.

Digital pathology (DP) is becoming more widely available and has been harnessed to enhance diagnosis and access to subspecialty opinion, promote education, and may also be deployed for remote reporting. DP has enabled the development of artificial intelligence (AI) in pathology, through image analysis and machine learning, including working toward open source access.

Pathologists at the Singapore General Hospital (Singapore) and their colleagues chose representative slides from 93 cases of PTs diagnosed between 2014 and 2015. The mean age ± SD of the cohort was 42.5 ± 12.7 years. Of these, 60 were benign, 31 borderline, and two malignant, which were graded based on the World Health Organization guidelines. Specifically, stromal hypercellularity and stromal atypia were categorized into mild, moderate, and marked, according to the consensus review.

The slides were scanned with the IntelliSite Ultra-Fast Scanner (Philips Digital Pathology Solutions, Eindhoven, the Netherlands) and viewed with the Philips’ Image Management System viewer. Mitotic counting was conducted on the whole slide image, before choosing 10 high powered fields (HPFs) and demarcating the tumor area in DP. Values of mitoses/mm2 were used to compare results between 10 HPFs and the whole slide. Correlations with clinicopathological parameters were conducted.

The scientists reported that in terms of atypia, 65 (70.0%) PT cases displayed mild atypia, followed by 27 (29.0%) moderate atypia and one (1%) marked atypia. For stromal cellularity, 50 (53.8%) tumors displayed moderate hypercellularity, followed by 31 (33.3%) mild hypercellularity and 12 (12.9%) marked hypercellularity. The mean size of the tumors was 4.6 ± 3.3 cm3 (mean ± SD cm3). Both whole slide counting of mitoses and 10 HPFs had similar statistically significant correlation coefficients with grade, stromal atypia, and stromal hypercellularity. Neither whole slide mitotic counts nor mitoses per 10 HPFs showed statistically significant correlations with patient age and tumor size.

The authors concluded that an accurate set of 10 HPFs that yielded a maximal mitotic count can be chosen after evaluating the whole slide. DP makes counting mitoses over a larger area subjectively easier, with the possibility of AI being used as facilitator and enabler. This could influence how to approach training, testing, and validation of future AI algorithms for mitotic counting. The study was published in the November. 2020 issue of the journal Archives of Pathology and Laboratory Medicine.

Related Links:
Singapore General Hospital
Philips Digital Pathology Solutions



Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.